Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Betulin, a naturally occurring abundant triterpene is converted in four steps to 3,28-di-O-acetyllupa-12,18-diene. When various 4-substituted urazoles were oxidized to the corresponding urazines with iodobenzene diacetate in the presence of 3,28-di-O-acetyllupa-12,18-diene, new heterocyclic betulin derivatives were produced. These betulin derivatives were examined in a microplate assay at 50 microM for their ability to inhibit the growth of Leishmania donovani axenic amastigotes, a species that causes the fatal visceral leishmaniasis. GI(50) (concentration for 50% growth inhibition) values of the most effective compounds were determined and their cytotoxicity on the human macrophage cell line THP-1 evaluated. The anti-leishmanial activity on L. donovani amastigotes growing in macrophages was also examined. The heterocycloadduct between 3,28-di-O-acetyllupa-12,18-diene and 4-methylurazine was the most effective derivative with an GI(50)=8.9 microM against L. donovani amastigotes.

Knowledge Graph

Similar Paper

Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives
Bioorganic & Medicinal Chemistry 2010.0
Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes
Med. Chem. Commun. 2014.0
Synthesis and structure–activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid
Bioorganic & Medicinal Chemistry 2010.0
Betulin derivatives impair Leishmania braziliensis viability and host–parasite interaction
Bioorganic & Medicinal Chemistry 2014.0
Synthesis of carboxyimidamide-substituted benzo[c][1,2,5]oxadiazoles and their analogs, and evaluation of biological activity against Leishmania donovani
MedChemComm 2015.0
Chemotherapy of leishmaniasis. Part XI: Synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives
Bioorganic & Medicinal Chemistry Letters 2012.0
Chemotherapy of leishmaniasis. Part XII: Design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-β-carbolines as antileishmanial agents
European Journal of Medicinal Chemistry 2010.0
Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents
European Journal of Medicinal Chemistry 2011.0
Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives
European Journal of Medicinal Chemistry 2016.0